Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11007139 Risperidone or paliperidone implant formulation
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
June 28, 2019
Date of Patent
May 18, 2021
Patent Application Number
16456900
Patent Citations
US Patent 10182982 Antipsychotic injectable depot composition
US Patent 10195138 Methods for the preparation of injectable depot compositions
US Patent 10285936 Injectable composition with aromatase inhibitor
US Patent 10350159 Paliperidone implant formulation
US Patent 10335366 Risperidone or paliperidone implant formulation
US Patent 10463607 Antipsychotic Injectable Depot Composition
US Patent 10058504 Methods for the preparation of injectable depot compositions
US Patent 10085936 Antipsychotic injectable depot composition
Patent Citations Received
US Patent 11752093 Antipsychotic injectable depot composition
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11007139
Patent Primary Examiner
Katherine Peebles
Find more entities like US Patent 11007139 Risperidone or paliperidone implant formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE